Pacific Palisades, CA, United States
Aadi Bioscience recalls
1 recall recorded since 2018, most recently on 13 October 2022. None are listed as ongoing. Status and classification are as published by the FDA.
Recalls1
Ongoing (FDA)0
Terminated or completed1
Class I (FDA)0
Terminated Class III Drugs
- Recall started
- 13 October 2022
- Terminated
- 16 March 2023
- Reason
- Failed Stability Specifications
- Distribution
- Within the U.S Market - PA, AL, KY, TN
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-0059-2023
- Fyarro (sirolimus protein-bound particles for injectable suspension (albumin-bound), 100 mg per vial, NDC 80803-153-50, manufactured for Aadi Bioscience, Inc, CA.
A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.